These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1874858)
21. Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one. Zhao YY; Qin XY; Cheng XL; Liu XY; Lin RC; Zhang Y; Li XY; Sun XL; Sun WJ Anal Chim Acta; 2010 Aug; 675(2):199-206. PubMed ID: 20800733 [TBL] [Abstract][Full Text] [Related]
22. Liquid chromatographic determination of sotalol in plasma and urine employing solid-phase extraction and fluorescence detection. Bartek MJ; Vekshteyn M; Boarman MP; Gallo DG J Chromatogr; 1987 Oct; 421(2):309-18. PubMed ID: 3429585 [TBL] [Abstract][Full Text] [Related]
23. Micellar electrokinetic chromatography as a fast screening method for the determination of the doping agents furosemide and piretanide in urine. Lalljie SP; Barroso MB; Steenackers D; Alonso RM; Jiménez RM; Sandra P J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):71-8. PubMed ID: 9029315 [TBL] [Abstract][Full Text] [Related]
24. High-throughput liquid-chromatography method with fluorescence detection for reciprocal determination of furosemide or norfloxacin in human plasma. Galaon T; Udrescu S; Sora I; David V; Medvedovici A Biomed Chromatogr; 2007 Jan; 21(1):40-7. PubMed ID: 17080503 [TBL] [Abstract][Full Text] [Related]
25. [Detection of selected diuretics in biological fluids by chromatography mass spectrometry]. Alikhodzhaeva MI; Simonov EA; Kirichek AV; Popkov VA Sud Med Ekspert; 2009; 52(5):27-9. PubMed ID: 20058847 [TBL] [Abstract][Full Text] [Related]
26. Determination of piretanide and furosemide in pharmaceuticals and human urine by high-performance liquid chromatography with amperometric detection. Barroso MB; Jiménez RM; Alonso RM; Ortiz E J Chromatogr B Biomed Appl; 1996 Jan; 675(2):303-12. PubMed ID: 8852719 [TBL] [Abstract][Full Text] [Related]
27. Quantitative determination of stanozolol and its metabolite in urine by gas chromatography/mass spectrometry. Choo HY; Kwon OS; Park J J Anal Toxicol; 1990; 14(2):109-12. PubMed ID: 2325376 [TBL] [Abstract][Full Text] [Related]
28. Systematic analysis of diuretic doping agents by HPLC screening and GC/MS confirmation. Park SJ; Pyo HS; Kim YJ; Kim MS; Park J J Anal Toxicol; 1990; 14(2):84-90. PubMed ID: 2325382 [TBL] [Abstract][Full Text] [Related]
29. Simple microscale high-performance liquid chromatographic method for determination of furosemide in neonatal plasma. Sidhu JS; Charles BG J Chromatogr; 1993 Jan; 612(1):161-5. PubMed ID: 8454695 [TBL] [Abstract][Full Text] [Related]
30. Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration. Lehner AF; Hughes CG; Harkins JD; Nickerson C; Mollett B; Dirikolu L; Bosken J; Camargo F; Boyles J; Troppmann A; Karpiesiuk WW; Woods WE; Tobin T J Anal Toxicol; 2004; 28(4):226-38. PubMed ID: 15189672 [TBL] [Abstract][Full Text] [Related]
31. Determination of phenylisothiocyanate derivatives of amphetamine and its analogues in biological fluids by HPLC-APCI-MS or DAD. Bogusz MJ; Kala M; Maier RD J Anal Toxicol; 1997; 21(1):59-69. PubMed ID: 9013295 [TBL] [Abstract][Full Text] [Related]
32. Accurate identification and quantification of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of a direct high efficiency liquid chromatographic-mass spectrometric method. Stephanson N; Josefsson M; Kronstrand R; Beck O J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):101-8. PubMed ID: 18620911 [TBL] [Abstract][Full Text] [Related]
33. Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution liquid chromatography-electrospray ionization-tandem mass spectrometry: comparison with gas chromatography-mass spectrometry. Chen HJ; Chang CM Chem Res Toxicol; 2004 Jul; 17(7):963-71. PubMed ID: 15257622 [TBL] [Abstract][Full Text] [Related]
34. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose. Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556 [TBL] [Abstract][Full Text] [Related]
35. Simplified method to quantify furosemide in urine by high-performance liquid chromatography and ultraviolet detection. Nava-Ocampo AA; Velázquez-Armenta EY; Reyes-Pérez H; Ramirez-Lopez E; Ponce-Monter H J Chromatogr B Biomed Sci Appl; 1999 Jun; 730(1):49-54. PubMed ID: 10437671 [TBL] [Abstract][Full Text] [Related]
36. GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: Inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays. Tsikas D; Wolf A; Mitschke A; Gutzki FM; Will W; Bader M J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2582-92. PubMed ID: 20462809 [TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatographic determination of metoprolol and alpha-hydroxymetoprolol concentrations in human serum, urine, and cerebrospinal fluid. Gengo FM; Ziemniak MA; Kinkel WR; McHugh WB J Pharm Sci; 1984 Jul; 73(7):961-3. PubMed ID: 6470961 [TBL] [Abstract][Full Text] [Related]
38. Plasma concentration of furosemide versus specific gravity of urine in predicting dose of administration in race horses. Uboh CE; Soma LR; Rudy JA; Morgan E; Mengeringhausen K; Sams R Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):201-18. PubMed ID: 1439190 [TBL] [Abstract][Full Text] [Related]
39. A sensitive assay method of furosemide in plasma and urine by high-performance liquid chromotography. Snedden W; Sharma JN; Fernandez PG Ther Drug Monit; 1982; 4(4):381-3. PubMed ID: 7157461 [TBL] [Abstract][Full Text] [Related]
40. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose. Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]